Adjuvant therapy for melanoma
In cases of high risk of melanoma recurrence, even after surgery, our specialists can suggest new methods that help to delay or prevent the recurrence of melanoma. It is called adjuvant therapy.
Adjuvant cancer therapy is an additional treatment that is recommended after the initial treatment of melanoma, usually surgical. The goal of adjuvant therapy is to reduce the risk of melanoma recurrence.
Our doctors recommends adjuvant therapy for patients with high-risk melanoma. High-risk melanoma is usually determined as melanoma that is located deeper, or it is more than 4 mm thick in the primary region or has affected nearby lymph nodes. Such patients have a high risk of recurrence, because some melanoma cells can remain in the body, even if the visible melanoma tumors have been successfully removed by surgery.
FDA approved adjuvant therapy for the treatment of melanoma:
♦ Ipilimumab (Yervoi)
♦ Pembrolizumab (Keytruda)
♦ Mekinist
♦ Tafinlar
Other treatments for melanoma:
⇒ Microsurgical operation (Mohs Surgery)
Should you like to get an opinion of a leading highly specialized Israeli doctor / surgeon on whether you are receiving the right treatment in your country or if there is more advanced treatment, including personalized and targeted therapy, please contact us. We will promptly coordinate an appointment and / or treatment in Israel.
info@resultmed.com
!מבקרים באתר היקרים, אנא שימו לב
.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד